openPR Logo
Press release

Pancreatic Fistula Market | Growth Prospects, Key Opportunities, Trends And Forecast 2024

08-14-2017 04:23 PM CET | Health & Medicine

Press release from: Transparency Market Research - Pharmaceutical

Pancreatic Fistula Market | Growth Prospects, Key

Global Pancreatic Fistula Market: Overview

Pancreatic fistula (PF) results from leakage of pancreatic fluid on account of disruption of pancreatic ducts. After pancreatic resection or acute/chronic pancreatitis, pancreatic ducts may disrupt and the fluid may leak out. If the leakage is beyond a certain limit and not dealt with in time, it can cause infection or excoriation, or morbidity in worst cases due to malnutrition.

Pancreatic fistula tends to aggravate the pancreatic resections both in case of acute as well as chronic tumors. Whether the fistula is internal or external, complications may also arise in case of necrosectomy after severe pancreatitis, and penetrating and blunt trauma.

A report by Transparency Market Research studies the global fistula market to understand its scope and trajectory. It attempts to present the different treatments which are being developed and also other aspects of the market. The report uncovers the evolving trends and dynamics in the market in terms in various ongoing trials. It also sheds light on different trials that have been discontinued.

View Report –
http://www.transparencymarketresearch.com/pancreatic-fistula-market.html

Global Pancreatic Fistula Market: Drivers and Restraints

The report by TMR finds that a lot of research and development is being carried out for the past one decade in the treatment for pancreatic fistula. For external and internal fistulae, for example, various therapeutic options are being considered such as percutaneous, medical, surgical, and endoscopic. On account of high levels of serum amylase and enzyme diffusion throughout the pleural or peritoneal surface, the diagnosis of pancreatic fistula entails endoscopic retrograde cholangiopancreatography (ERCP) and contrast-enhanced computed tomography (CECT). ERCP, however, is considered a crucial component for treatment.

The main treatment entails arresting the pancreatic enzyme production. When patients are subjected to long-acting somatostatin analogues, their oral intake is reduced substantially. The treatment with parenteral nutrition is provided for a couple of weeks and if no improvement is seen, endoscopic or surgical treatment is suggested in most of the cases. In case of a surgery, ERCP is used for uncovering the leakage site. The involved part of fistula is then removed by fistulectomy.

As far as treatment for pancreatic fistula are concerned, a lot of money is being ploughed into researching better and more effective methods. The pancreatic fistula market for treatment foresees flourishing prospects in the near future.

Global Pancreatic Fistula Market: Geographical Segmentation

The report by Transparency Market Research bundles information on the different clinical trials being carried out in Europe, North America, South and Central America, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations. It supplies information whether the trial is complete or still in progress and trial success rate.

Global Pancreatic Fistula Market: Competitive Landscape

The report studies the key players involved in breakthrough research and development on pancreatic fistula.

Major regions analyzed under this research report are:

Eastern Europe (Poland and Russia)
Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
North America (U.S. and Canada)
Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
Middle East and Africa (GCC, Southern Africa, and North Africa)
Latin America (Mexico, Brazil, Peru, Chile, and others)

Request a brochure of this report to know what opportunities will emerge in the rapidly evolving Pancreatic Fistula Market during 2016- 2024
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=14768

About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pancreatic Fistula Market | Growth Prospects, Key Opportunities, Trends And Forecast 2024 here

News-ID: 668464 • Views:

More Releases from Transparency Market Research - Pharmaceutical

Neurovascular Devices Market Business Opportunities and Growth Challenges Report
Neurovascular Devices Market Business Opportunities and Growth Challenges Report
Global Neurovascular Devices Market: Overview The global population is aging rapidly. According to WHO, the chances of health risks are greater in geriatric people than the young generation. Old age is considered to be one of the biggest risk factors that are responsible for developing various diseases such as cardiovascular and neurological conditions. It is because of these factors, the global neurovascular devices market is experiencing robust growth in the
Pneumococcal Vaccines Market anticipated expand at a CAGR of 3.3% from 2018 to 2026
Pneumococcal Vaccines Market anticipated expand at a CAGR of 3.3% from 2018 to 2 …
Transparency Market Research (TMR) has published a new report titled, “Pneumococcal Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”. According to the report, the global pneumococcal vaccines market was valued at US$ 7,247.6 Mn in 2017 and is anticipated expand at a CAGR of 3.3% from 2018 to 2026. Increase in patient pool, growth of the pharmaceutical industry, government initiatives to increase vaccination programs, rise
Swab and Viral Transport Medium Market projected to expand at a CAGR of ~3% from 2020 to 2030
Swab and Viral Transport Medium Market projected to expand at a CAGR of ~3% from …
Swab and Viral Transport Medium Market: Introduction Transparency Market Research has published a new report titled, ‘Global Swab and Viral Transport Medium Market ’. According to the report, the global swab and viral transport medium market was valued at US$ 0.9 Bn in 2019 and is projected to expand at a CAGR of ~3% from 2020 to 2030. Viral transport medium (VTM) enables safe transfer of viruses, chlamydia, and mycoplasma for
Radiofrequency Ablation Devices Market by Product, Geography and Forecast to 202 …
Transparency Market Research (TMR) has published a new report titled, 'Radiofrequency Ablation Devices for Pain Management Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019-2027'. According to the report, the global radiofrequency ablation devices for pain management market was valued at US$ 543.0 Mn in 2018 and is projected to expand at a CAGR of above 11.0% from 2019 to 2027. Overview Radiofrequency ablation is a minimally invasive surgical

All 5 Releases


More Releases for Pancreatic

Pancreatic Cancer Therapy Market: Rise in Number of Patients Suffering with Panc …
Pancreatic cancer is one of the aggressive cancers that originate in the tissues of the pancreas and rapidly spreads to the nearby organs. Pancreatic cancer is the 12th most commonly occurring cancer in the world. According to the American Cancer Society, ~55,440 patients in the US are expected to be diagnosed with pancreatic cancer in 2018. Moreover, the ACS also reports that pancreatic cancer is the third leading cause of
Pancreatic Cancer Treatment
Pancreatic Cancer Treatment Market describes its growth, size, share, Forecast and trends to 2025 Pancreatic Cancer Treatment Market Production and Demand Analysis 2019 to 2025 Pancreatic Cancer Treatment Market 2019 Manufacturing Analysis and Development Forecast 2025 Pancreatic Cancer Treatment Market 2019: Recent Study Including Growth Factors, Regional Drivers, Forecast 2025 Pancreatic Market to Insight By 2025: Top Key Vendors Pancreatic cancer arises when cells in the pancreas, a glandular organ behind the stomach, begin to
Exocrine Pancreatic Insufficiency (EPI) Therapeutics- Pipeline Analysis
Exocrine pancreatic insufficiency (EPI) is the inability of pancreas to produce enough enzymes for the proper breakdown and absorption of nutrients. The common causes of EPI are damage to pancreas, inflammation of pancreas, pancreatic surgery, and inherited disorders like Crohn’s disease and celiac disease. Download the sample report at: https://www.pharmaproff.com/request-sample/1024 Some symptoms observed during EPI are pain or tenderness in belly, bad-smelling bowel movements, gas, diarrhea and feeling of fullness. EPI
Pancreatic Cancer Pipeline Review H1 2019
Pancreatic Cancer - Pipeline Review, H1 2017 Summary Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Pancreatic Cancer - Pipeline Review, H1 2017, provides an overview of the Pancreatic Cancer (Oncology) pipeline landscape. Pancreatic cancer is a disease in which malignant (cancer) cells are found in the tissues of the pancreas. This is also called exocrine cancer. Signs and symptoms include upper abdominal pain that may radiate to back, yellowing of skin and
Pancreatic Cancer Drug Pipeline Analysis
“Pancreatic Cancer Drug Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various drug profiles being developed for the treatment of Pancreatic Cancer. Research report covers all the ongoing drug development in various phases. Each drug profiles include detailed information like: Originator, Owner, Collaborator, Technology Provider, Licensee, Development Phase, Development Indications, Mechanism of Action, Chemical Formula, Country of Development and detailed analysis on the development process. Insight for each
Exocrine Pancreatic Insufficiency Market 2013
Transparency Market Research has published a new market report titled, “Exocrine Pancreatic Insufficiency Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2013 – 2023.” According to the report, the exocrine pancreatic insufficiency market is anticipated to expand at a CAGR of 8.3% from 2015 to 2023 to reach US$2.85 Bn by 2023. Browse the full Exocrine Pancreatic Insufficiency Market – (Therapeutic – Pancreatic Enzyme Replacement Therapy (Creon, Zenpep,